Indeed, Glycyl-tRNA synthetase (GARS) dominant mutations have been described in inherited neuropathies such as CMT2D and dHMN with upper limb predominance (dHMN-V; Xie et al., 2007; Antonellis and Green, 2008). This evidence concerns the gene GARS1 and distal hereditary motor neuropathy.